Recent news on Iopromide

Sustainability of energy, food and water theme of ACS national meeting  -  Mar 25, 2007
EurekAlert (press release),...musk ketone (a synthetic fragrance) and iopromide (an x-ray contrast media), according to Shane Snyder, a researcher with the Water Authority.

Berlex Voluntarily Recalls Ultravist(R) (Iopromide Injection) ...  Jul 31, 2006
US affiliate of Schering AG, Germany, is voluntarily recalling all lots of its X-ray contrast agent Ultravist(R) Injection 370 mgI/mL (iopromide injection), as ... -DG News

Schering Recalls X-ray Contrast Following Complaints Of ...  Jul 31, 2006
AG (SHR | charts | news | PowerRating), a drug maker, revealed a decision to voluntarily recall all x-ray contrast agent, Ultravist or iopromide injection 370 ... -Trading Markets

Berlex Updates Ultravist Recall  Aug 2, 2006
Berlex has updated its Ultravist (iopromide) injection recall to include all lots of the 370 mgI/mL x-ray contrast agent due to the potential presence of ... -Facts and Comparisons

Schering Voluntarily Recalls Ultravist(R) Injection 370 mgI/ml  Jul 31, 2006
Schering AG, Germany (FSE: SCH, NYSE: SHR) is voluntarily recalling its X-ray contrast agent Ultravist® Injection 370 mgI/ml (iopromide injection) due to the ... -Yahoo! News

euro adhoc: Schering AG /  Jul 31, 2006
31.07.2006 Schering AG, Germany is voluntarily recalling its X-ray contrast agent Ultravist Injection 370 mgI/mL (iopromide injection) due to the potential ... -news aktuell (Pressemitteilung)

Schering Voluntarily Recalls Ultravist Injection 370 mgI/ml  Jul 31, 2006
PRNewswire-FirstCall/ -- Schering AG, Germany is voluntarily recalling its X-ray contrast agent Ultravist(R) Injection 370 mgI/ml (iopromide injection) due to ... -PharmaLive.com

Schering voluntarily recalls Ultravist® Injection 370 mgI/ml  Jul 31, 2006
2006, Schering AG, Germany (FSE: SCH, NYSE: SHR) is voluntarily recalling its X-ray contrast agent Ultravist® Injection 370 mgI/ml (iopromide injection) due ... -WebWire

Schering pulls Ultravist, unveils mixed Leukine data, but Bayer ...  Aug 1, 2006
Schering AG yesterday pulled its X-ray contrast agent Ultravist (iopromide injection) from most global markets after a potential safety issue was uncovered and ... -Pharma Times (subscription)

Berlex Recalls Singe Lot of Ultravist  Jul 26, 2006
41500A, date 1/2007) of its intravenous x-ray contrast agent Ultravist (iopromide) 370 mgl/mL, 125 mL injection due to the presence of particulate matter in ... -Facts and Comparisons

Berlex Recalls Nationwide Single Lot of Ultravist  22 Jul 2006
41500A) of its intravenous X-ray contrast agent, Ultravist® Injection 370 mgI/mL, 125 mL, (iopromide injection) NDC 50419-246-12, EXP 01/2007, due to the ... -Kansas City infoZine



First-pass myocardial perfusion may be assessed visually ...  Mar 30, 2006
..."Dynamic contrast-enhanced MDCT (12x1.5 mm, 120 kV, 30 mAs, 64 acquisitions, 40 ml iopromide 370@4ml/s) and contrast-enhanced first-pass perfusion magnetic ... - Therapeutics Daily (subscription)

Pharmaceutical Metabolites Found in Wastewater  Mar 15, 2006
In research published in January in Analytical Chemistry, the UB chemists also found that iopromide, a pharmaceutical imaging agent that patients consume ... - UB News Center

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional